Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure

Pironi, L; Steiger, E; Joly, F; Wanten, GJA; Chambrier, C; Aimasso, U; Sasdelli, AS; Szczepanek, K; Jukes, A; Theilla, M; Kunecki, M; Daniels, J; Serlie, MJ; Cooper, SC; Poullenot, F; Rasmussen, HH; Compher, CW; Crivelli, A; Hughes, SJ; Santarpia, L; Guglielmi, FW; Kozjek, NR; Ellegard, L; Schneider, SM; Matras, P; Forbes, A; Wyer, N; Zmarzly, A; Taus, M; O’Callaghan, M; Osland, E; Thibault, R; Cuerda, C; Jones, L; Chapman, B; Sahin, P; Virgili, NM; Lee, ADW; Orlandoni, P; Matysiak, K; Di Caro, S; Doitchinova-Simeonova, M; Masconale, L; Spaggiari, C; Garde, C; Serralde-Zuniga, AE; Olveira, G; Krznaric, Z; Jauregui, EP; Murillo, AZ; Suarez-Llanos, JP; Nardi, E; Van Gossum, A; Lal, S – 2020